Thursday, November 17, 2011

Assignment 2 Question 2

Who will benefit if the company follows your recommendation?

As described in question 1, it isn’t clever to take unnecessary risk especially for a start-up company that is newly established even if the problem is minimum. A single problem with the problem in this case can effect people’s lives. I believe that we should take appropriate action that can reduce risks that can jeopardize our company and people's lives.

The decisions has effect on the company, the hospital administration and the patients. If we decide to take the risk to release the product next week and the product becomes defective, it can cause a great loss to the company and our reputation. By postponing the release date to analyze the product, we can avoid the product into becoming defective and cause the company some problems. Although we wouldn’t t be “first to market”, but it is acceptable to be in the 2nd place instead of having a product that doesn’t work.

This will also benefit the hospital administration. Although our company may lose a client, but the sensible thing to do is warn them that our product may malfunction and needs to be analyze and tested before release, especially if the product involve around human lives. Hospital staff such as doctors and nurses can avoid many problems that is critical when they are taking care of sick and disabled people. With a defective product, it can effects the work done by the hospital staff to their patients. If procedures such as surgery or medicine is wrongly executed, patients have the rights to sue to hospital. They can also avoid any complications such as patient’s data is corrupted or lost.

I believe that we have made the right decision by not releasing the product next week so that we can properly analyze, debug, and test the product to function properly. Since we won’t be the “first to market”, we can use that time to improve and upgrade so that we can release a better product than the rival’s company and avoid from being out of business.

No comments:

Post a Comment